FemiClear Genital Herpes Symptoms Multisymptom

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
FemiClear Genital Herpes Symptoms Multisymptom
Generic name
LEMONGRASS, WILLOW BARK EXTRACT
Manufacturer
Organicare Nature's Science, LLC
Product type
HUMAN OTC DRUG
SPL set ID
dc29ab2b-9ec2-65d2-e053-2995a90a2a31
SPL ID
419b458f-2557-8c75-e063-6394a90ae59b
Version
5
Effective date
2025-10-20
Source export date
2026-10-12
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:14:29
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. FemiClear is not a cure for herpes and will not prevent future outbreaks. This product will not stop the spread of the herpes viruses or other viruses. Viral infections are contagious. FemiClear does not prevent other sexually transmitted infections (STIs). Practice safer sex by using latex or polyurethane condom to reduce risk of getting STIs. FemiClear may damage condoms and diaphragms and cause ethem to fail

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.